(2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol

C13H22N2O10 — CID 137295320

IUPAC(2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol
SMILESOC[C@H]1O[C@H](/N=C2\N[C@@H]3[C@H](O2)[C@@H](O)[C@H](O)[C@]3(O)CO)C(O)C(O)[C@@H]1O
InChIInChI=1S/C13H22N2O10/c16-1-3-4(18)5(19)6(20)11(24-3)15-12-14-9-8(25-12)7(21)10(22)13(9,23)2-17/h3-11,16-23H,1-2H2,(H,14,15)/t3-,4-,5?,6?,7-,8-,9-,10+,11+,13+/m1/s1
InChIKeyNRKVPNOUINUNKY-LACBGQSXSA-N
MW366.32 g/mol
LogP-6.04
Rot. Bonds3

About (2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol

(2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol (PubChem CID 137295320) has the molecular formula C13H22N2O10 and a molecular weight of 366.32 g/mol. Its IUPAC name is (2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol.

Molecular Properties

Compound Name(2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol
PubChem CID137295320
Molecular FormulaC13H22N2O10
Molecular Weight366.32 g/mol
Exact Mass366.13
IUPAC Name(2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol
SMILESOC[C@H]1O[C@H](/N=C2\N[C@@H]3[C@H](O2)[C@@H](O)[C@H](O)[C@]3(O)CO)C(O)C(O)[C@@H]1O
InChIInChI=1S/C13H22N2O10/c16-1-3-4(18)5(19)6(20)11(24-3)15-12-14-9-8(25-12)7(21)10(22)13(9,23)2-17/h3-11,16-23H,1-2H2,(H,14,15)/t3-,4-,5?,6?,7-,8-,9-,10+,11+,13+/m1/s1
InChIKeyNRKVPNOUINUNKY-LACBGQSXSA-N
XLogP-6.04
TPSA204.69 Ų
H-Bond Donors9
H-Bond Acceptors11
Rotatable Bonds3
Heavy Atoms25
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500366.32
LogP ≤ 5-6.04
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze (2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol?
The IUPAC name of (2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol (CID 137295320) is (2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol.
What is the SMILES notation for (2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol?
The canonical SMILES for (2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol is OC[C@H]1O[C@H](/N=C2\N[C@@H]3[C@H](O2)[C@@H](O)[C@H](O)[C@]3(O)CO)C(O)C(O)[C@@H]1O.
What is the InChIKey of (2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol?
The InChIKey is NRKVPNOUINUNKY-LACBGQSXSA-N. The full InChI is InChI=1S/C13H22N2O10/c16-1-3-4(18)5(19)6(20)11(24-3)15-12-14-9-8(25-12)7(21)10(22)13(9,23)2-17/h3-11,16-23H,1-2H2,(H,14,15)/t3-,4-,5?,6?,7-,8-,9-,10+,11+,13+/m1/s1.
What are the key properties of (2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol?
(2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol has a molecular weight of 366.32 g/mol, XLogP of -6.04, 3 rotatable bonds, 9 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (2E,3aR,4R,5S,6S,6aS)-4-(hydroxymethyl)-2-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]imino-3a,5,6,6a-tetrahydro-3H-cyclopenta[d][1,3]oxazole-4,5,6-triol is sourced from PubChem (CID 137295320), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).